Furthermore, the tissue damage associated with the surgical incisions would also induce platelet adherence and localization, thereby concentrating the P-aPD-1 to the area near the tumor, rather than wide-systemic distribution as seen with intravenous administration of checkpoint inhibiting monoclonal antibodies. The gene discussed is MTPAP; the disease is neoplasm.